Clinical Trials Logo

Filter by:
NCT ID: NCT00934011 Completed - Septic Shock Clinical Trials

Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections

Start date: September 2009
Phase: N/A
Study type: Interventional

In this study the investigators aim to test if C-reactive protein (CRP)or procalcitonin(PCT) - guided strategy allows to reduce the antibiotic use in patients wiht severe sepsis and septic shock. Therefore, the safety of this intervention will be carefully measured.

NCT ID: NCT00933946 Completed - Hygiene Clinical Trials

Dermacyd Silver Frutal (Lactic Acid) - Compatibility.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Silver Frutal.

NCT ID: NCT00933907 Completed - Hygiene Clinical Trials

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Compatibility - Stay on Frutal

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd PHDESILSTYFR.

NCT ID: NCT00933842 Completed - Hygiene Clinical Trials

Dermacyd PH_DESILSTY_FL (Lactic Acid) - Photo Evaluation - Stay on Floral

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd PHDESILSTYFL. Secondary Objective:

NCT ID: NCT00933712 Completed - Hygiene Clinical Trials

Dermacyd Silver Floral (Lactic Acid) - Compatibility.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Silver Floral

NCT ID: NCT00933699 Completed - Hygiene Clinical Trials

Dermacyd PH_DESILSTY_FL (Lactic Acid) - Acceptability - Stay on Floral.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To prove the safety of the gynaecological formulation in normal conditions of use.

NCT ID: NCT00933647 Recruiting - Obesity Clinical Trials

Cardioprotective Effects of Green Tea Versus Maté Intake

Start date: November 2007
Phase: Phase 3
Study type: Interventional

The investigators aim to study the effects of green tea and maté consumption on lipid and inflammatory profiles in dyslipidemic and overweight subjects.

NCT ID: NCT00933569 Completed - Hygiene Clinical Trials

Dermacyd Silver Floral (Lactic Acid) - Acceptability.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To prove the safety of the gynaecological formulation in normal conditions of use.

NCT ID: NCT00933504 Completed - Hygiene Clinical Trials

Dermacyd Silver Floral (Lactic Acid) - Compatibility - Stay on Floral

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd PHDESILSTYFL.

NCT ID: NCT00933413 Completed - Hygiene Clinical Trials

Dermacyd Silver Frutal (Lactic Acid) - Acceptability.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To prove the safety of the gynecological formulation in normal conditions of use.